Daniel O’Day, Chairman & CEO, Gilead Sciences, recently sent an open letter to the American Public, indicating why its U.S. Patented drug Remdesivir to treat the coronavirus will be a company $$ bonanza with its new pricing. Because of the way the U.S. system is set up and the discounts that government healthcare programs expect, … Continue reading Gilead coronavirus drug is $3,100. We can’t purchase India’s generic for 1/4 the price!
China Set to Patent Gilead’s Experimental Coronavirus Drug
Follow the money! The esteemed investor site The Motley Fool explained this week: The drug (Remdesivir) could see over $1 billion in sales in the course of the entire coronavirus outbreak, due to the sheer number of patients infected and potentially at risk for the virus. This is assuming the drug can treat up to … Continue reading China Set to Patent Gilead’s Experimental Coronavirus Drug
The lobbyists in the Trump woodpile, or how the President dumped drug price reforms to please Joe Grogan and Pharma
Who is Joe Grogan? Hint: he is not the famous comedian - Joe Rogan. Here's the graph of his resume - revolving from industry to government and now the White House - enough to make your head spin from such swinging roles. Is it possible for any lobbyist from Gilead Sciences to be fair and … Continue reading The lobbyists in the Trump woodpile, or how the President dumped drug price reforms to please Joe Grogan and Pharma